Philips ClearVue 850
The Philips ClearVue 850 Ultrasound is a midrange imaging system designed primarily for women’s health while also excelling in vascular, cardiac, small parts, and echo examinations. Building on the ClearVue architecture, the 850 introduces advanced features such as iScan, AutoSCAN, SonoCT, and XRES to significantly enhance image quality. It offers expanded 4D imaging options—including 4D Convex, 4D transvaginal, Auto Face Reveal, iSlice, and Fetal STIC—enabling detailed visualization and analysis of volume data. The system is equipped with a 19-inch, 360-degree articulating monitor and an ergonomically advanced, height-adjustable control panel for optimal user comfort, along with quick action buttons for frequently used obstetric measurements.
Key Points:
-
Advanced Imaging for Women’s Health:
- Optimized for obstetric, gynecologic, and fetal imaging, while also supporting vascular, cardiac, small parts, and echo exams.
-
Enhanced 2D, 3D, and 4D Capabilities:
- Offers comprehensive imaging options with additional 4D modes like 4D Convex, 4D transvaginal, Auto Face Reveal, iSlice, and Fetal STIC.
-
Cutting-Edge Technologies:
- Integrates iScan, AutoSCAN, SonoCT, and XRES to reduce artifacts and automatically optimize image scale and contrast.
-
User-Centric Design:
- Features a 19-inch, 360-degree articulating monitor, tilt/swivel capability, and an ergonomically advanced console with height-adjustable control panel.
- Quick action buttons streamline obstetric measurements and imaging mode selection.
-
Comprehensive Diagnostic Tools:
- Includes stress echo, strain elastography, pulse inversion harmonics, FloVue advanced imaging for direct blood flow visualization, and automated IMT imaging.
-
Efficient and Robust Performance:
- Built on a digital beamformer architecture with an adjustable dynamic range up to 120 dB and displayed imaging depth of up to 33 cm.
- Energy-efficient design ensures low power consumption while delivering high-quality imaging.
o3-mini-high

Reviews
There are no reviews yet.